Our partnership with enlightenbio on the next generation sequencing (NGS) market research report
We are pleased to annouce that we partnered with enlightenbio and contributed to the patent analysis section of the Clinical NGS Process Report January 2018 by enlightenbio on next generation sequencing (NGS) technology
released on January 12, 2018
with IP analysis contributed by Pramoedya Biointelligence LLC
The Clinical NGS Process Report by enlightenbio details the observations and learnings across the complex, multi-step informatics aspects following clinical NGS sample preparation and sequencing, and which includes data analysis, knowledge extraction, and clinical reporting of actionable findings. Market trends, including listing of major initiatives, merger and acquisitions, and a summary of patents are detailed within the report, while also highlighted are clinical customer/end-users’ unmet interpretation and knowledge extraction needs and challenges, and genetic testing lab preferences. Finally, an extensive comparison of solution providers in the SaaS and PaaS sector for the analysis and interpretation of clinical NGS data is included.
To purchase this report with a 10% discount, please apply Promo Code PRAMOEDYA10OFF